Libtayo® (cemiplimab) in Combination with Chemotherapy Receives Positive CHMP Opinion for the Treatment of Advanced PD-L1 Positive Non-small Cell Lung Cancer (NSCLC)
Recommendation based on a Phase 3 trial demonstrating superior survival outcomes for Libtayo plus chemotherapy…
Indonesia seeks to preserve historic railway assets as part of global heritage
Gigawatts Are Announced. Megawatts Must Be Energized.
Noah Kangian Adds 100+ New Services to MSP Panel’s Indian SMM Panel Service List
Astra Security Named Best Autonomous Pentesting Tool of 2026